Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RVNC | Revance Therapeutics, Inc. | Director | $196K | May 1, 2024 | ||
TXMD | TherapeuticsMD, Inc. | Director | $18.2K | Sep 29, 2022 | ||
LCTX | Lineage Cell Therapeutics, Inc. | Director | Jul 1, 2024 | |||
MNKPF | Mallinckrodt plc | Director | Jun 16, 2022 | |||
GPCR | Structure Therapeutics Inc. | Director | Aug 26, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|